• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞免疫与保护人体免受大流行性流感症状感染的相关性。

Cellular immune correlates of protection against symptomatic pandemic influenza.

机构信息

Respiratory Infections Section, National Heart and Lung Institute, Imperial College London, London, UK.

出版信息

Nat Med. 2013 Oct;19(10):1305-12. doi: 10.1038/nm.3350. Epub 2013 Sep 22.

DOI:10.1038/nm.3350
PMID:24056771
Abstract

The role of T cells in mediating heterosubtypic protection against natural influenza illness in humans is uncertain. The 2009 H1N1 pandemic (pH1N1) provided a unique natural experiment to determine whether crossreactive cellular immunity limits symptomatic illness in antibody-naive individuals. We followed 342 healthy adults through the UK pandemic waves and correlated the responses of pre-existing T cells to the pH1N1 virus and conserved core protein epitopes with clinical outcomes after incident pH1N1 infection. Higher frequencies of pre-existing T cells to conserved CD8 epitopes were found in individuals who developed less severe illness, with total symptom score having the strongest inverse correlation with the frequency of interferon-γ (IFN-γ)(+) interleukin-2 (IL-2)(-) CD8(+) T cells (r = -0.6, P = 0.004). Within this functional CD8(+)IFN-γ(+)IL-2(-) population, cells with the CD45RA(+) chemokine (C-C) receptor 7 (CCR7)(-) phenotype inversely correlated with symptom score and had lung-homing and cytotoxic potential. In the absence of crossreactive neutralizing antibodies, CD8(+) T cells specific to conserved viral epitopes correlated with crossprotection against symptomatic influenza. This protective immune correlate could guide universal influenza vaccine development.

摘要

T 细胞在介导针对人类自然流感疾病的异亚型保护中的作用尚不确定。2009 年 H1N1 大流行(pH1N1)提供了一个独特的自然实验,以确定交叉反应性细胞免疫是否限制了无抗体个体的症状性疾病。我们通过英国大流行波跟踪了 342 名健康成年人,并将对 pH1N1 病毒和保守核心蛋白表位的预先存在的 T 细胞反应与 pH1N1 感染后的临床结果相关联。在发生 pH1N1 感染后病情较轻的个体中,发现预先存在的 T 细胞对保守 CD8 表位的频率更高,总症状评分与干扰素-γ(IFN-γ)(+)白细胞介素-2(IL-2)(-)CD8(+)T 细胞频率呈最强负相关(r = -0.6,P = 0.004)。在这个功能性 CD8(+)IFN-γ(+)IL-2(-)群体中,CD45RA(+)趋化因子(C-C)受体 7(CCR7)(-)表型的细胞与症状评分呈负相关,具有肺归巢和细胞毒性潜力。在缺乏交叉中和抗体的情况下,针对保守病毒表位的 CD8(+)T 细胞与针对症状性流感的交叉保护相关。这种保护性免疫相关性可以指导通用流感疫苗的开发。

相似文献

1
Cellular immune correlates of protection against symptomatic pandemic influenza.细胞免疫与保护人体免受大流行性流感症状感染的相关性。
Nat Med. 2013 Oct;19(10):1305-12. doi: 10.1038/nm.3350. Epub 2013 Sep 22.
2
Predominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults.在未感染过甲型 H1N1 流感的成年人群中,优势为异亚型 IFN-γ 分泌型效应记忆 T 细胞。
Eur J Immunol. 2012 Nov;42(11):2913-24. doi: 10.1002/eji.201242504. Epub 2012 Aug 15.
3
Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination.大流行 H1N1 流感后一年加拿大队列的体液和细胞介导免疫:对疫苗接种的影响。
PLoS One. 2011;6(11):e28063. doi: 10.1371/journal.pone.0028063. Epub 2011 Nov 23.
4
Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy.不同的T细胞和自然杀伤细胞群体可能作为孕期预防甲型H1N1流感大流行病毒感染出现症状的免疫相关指标。
PLoS One. 2017 Nov 16;12(11):e0188055. doi: 10.1371/journal.pone.0188055. eCollection 2017.
5
A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.一种介导肺驻留记忆性CD8 T细胞诱导的新型疫苗接种策略赋予针对未来大流行性流感病毒的异源亚型免疫力。
J Immunol. 2016 Mar 15;196(6):2637-45. doi: 10.4049/jimmunol.1501637. Epub 2016 Feb 10.
6
Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.由季节性人流感产生的细胞毒性T淋巴细胞可与2009年甲型H1N1流感病毒发生交叉反应。
J Virol. 2010 Jul;84(13):6527-35. doi: 10.1128/JVI.00519-10. Epub 2010 Apr 21.
7
Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients.实体器官移植受者中对大流行性流感 A/H1N1 感染的长期免疫应答。
PLoS One. 2011;6(12):e28627. doi: 10.1371/journal.pone.0028627. Epub 2011 Dec 14.
8
Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.急性传染性单核细胞增多症的严重程度与交叉反应性流感 CD8 T 细胞受体库相关。
mBio. 2017 Dec 5;8(6):e01841-17. doi: 10.1128/mBio.01841-17.
9
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.预先存在的流感特异性 CD4+ T 细胞与人类对抗流感挑战的疾病保护相关。
Nat Med. 2012 Jan 29;18(2):274-80. doi: 10.1038/nm.2612.
10
Epitope specific T-cell responses against influenza A in a healthy population.健康人群中针对甲型流感的表位特异性T细胞应答。
Immunology. 2016 Feb;147(2):165-77. doi: 10.1111/imm.12548. Epub 2015 Dec 8.

引用本文的文献

1
Immunogenicity as a Predictor of Influenza Vaccine Efficacy: A Systematic Review.免疫原性作为流感疫苗效力的预测指标:一项系统综述
Vaccines (Basel). 2025 Aug 14;13(8):859. doi: 10.3390/vaccines13080859.
2
Challenges to the Effectiveness and Immunogenicity of COVID-19 Vaccines: A Narrative Review with a Systematic Approach.新冠疫苗有效性和免疫原性面临的挑战:一项采用系统方法的叙述性综述
Vaccines (Basel). 2025 Jul 24;13(8):789. doi: 10.3390/vaccines13080789.
3
Preliminary results on novel adjuvant combinations suggest enhanced immunogenicity of whole inactivated pandemic influenza vaccines.

本文引用的文献

1
Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.无中和抗体时的交叉反应性流感特异性抗体依赖的细胞细胞毒性抗体。
J Immunol. 2013 Feb 15;190(4):1837-48. doi: 10.4049/jimmunol.1201574. Epub 2013 Jan 14.
2
Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.针对季节性流感 A 病毒的人 T 细胞与 2009 年大流行流感 A(H1N1)和猪源三重重配 H3N2 流感病毒发生交叉反应。
J Gen Virol. 2013 Mar;94(Pt 3):583-592. doi: 10.1099/vir.0.048652-0. Epub 2012 Nov 14.
3
新型佐剂组合的初步结果表明,全灭活大流行性流感疫苗的免疫原性增强。
Front Drug Deliv. 2024 Jul 16;4:1382266. doi: 10.3389/fddev.2024.1382266. eCollection 2024.
4
Human T Cell Responses to Flavivirus Vaccines.人类T细胞对黄病毒疫苗的反应。
Eur J Immunol. 2025 Aug;55(8):e70027. doi: 10.1002/eji.70027.
5
High-dimensional single-cell phenotyping unveils persistent differences in immune cell profiles between severe and moderate seasonal influenza.高维单细胞表型分析揭示了重度和中度季节性流感之间免疫细胞谱的持续差异。
Front Immunol. 2025 Jul 22;16:1576861. doi: 10.3389/fimmu.2025.1576861. eCollection 2025.
6
Lung structural cells are altered by infeluenza virus leading to rapid immune protection following re-challenge.流感病毒会改变肺结构细胞,从而在再次感染后实现快速免疫保护。
Nat Commun. 2025 Aug 1;16(1):7061. doi: 10.1038/s41467-025-62364-y.
7
Aging and Viral Evolution Impair Immunity Against Dominant Pan-Coronavirus-Reactive T Cell Epitope.衰老和病毒进化削弱针对主要泛冠状病毒反应性T细胞表位的免疫力。
Eur J Immunol. 2025 Jul;55(7):e51888. doi: 10.1002/eji.202551888.
8
Central memory T cells with key TCR repertoires and gene expression profiles dominate influenza CD8+ T cell pools across the human lifespan.具有关键TCR库和基因表达谱的中枢记忆T细胞在人类一生中主导着流感特异性CD8+T细胞库。
Proc Natl Acad Sci U S A. 2025 Jul 29;122(30):e2501167122. doi: 10.1073/pnas.2501167122. Epub 2025 Jul 22.
9
Oral live attenuated polio vaccines induce enhanced T-cell responses with broad antigen recognition compared to inactivated polio vaccines.与灭活脊髓灰质炎疫苗相比,口服减毒活脊髓灰质炎疫苗可诱导具有广泛抗原识别能力的增强型T细胞反应。
medRxiv. 2025 May 21:2025.05.20.25328004. doi: 10.1101/2025.05.20.25328004.
10
Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza vaccine with bacterial cell membrane-derived adjuvants.基于神经氨酸酶的鼻腔内流感疫苗与细菌细胞膜衍生佐剂的免疫原性和保护效果
NPJ Vaccines. 2025 Jul 10;10(1):149. doi: 10.1038/s41541-025-01209-7.
Predominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults.
在未感染过甲型 H1N1 流感的成年人群中,优势为异亚型 IFN-γ 分泌型效应记忆 T 细胞。
Eur J Immunol. 2012 Nov;42(11):2913-24. doi: 10.1002/eji.201242504. Epub 2012 Aug 15.
4
Marked differences in CCR5 expression and activation levels in two South African populations.在两个南非人群中,CCR5 的表达和激活水平存在显著差异。
Immunology. 2012 Aug;136(4):397-407. doi: 10.1111/j.1365-2567.2012.03592.x.
5
IFITM3 restricts the morbidity and mortality associated with influenza.IFITM3 限制了流感相关的发病率和死亡率。
Nature. 2012 Mar 25;484(7395):519-23. doi: 10.1038/nature10921.
6
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.预先存在的流感特异性 CD4+ T 细胞与人类对抗流感挑战的疾病保护相关。
Nat Med. 2012 Jan 29;18(2):274-80. doi: 10.1038/nm.2612.
7
Validation of self-swab for virologic confirmation of influenza virus infections in a community setting.在社区环境中,自我采样用于流感病毒感染的病毒学确认的验证。
J Infect Dis. 2012 Feb 15;205(4):631-4. doi: 10.1093/infdis/jir803. Epub 2011 Dec 23.
8
Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates.交叉反应性 T 细胞参与了非人类灵长类动物中 2009 年大流行性 H1N1 流感病毒的快速清除。
PLoS Pathog. 2011 Nov;7(11):e1002381. doi: 10.1371/journal.ppat.1002381. Epub 2011 Nov 10.
9
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.流感疫苗的疗效和效果:系统评价和荟萃分析。
Lancet Infect Dis. 2012 Jan;12(1):36-44. doi: 10.1016/S1473-3099(11)70295-X. Epub 2011 Oct 25.
10
Characterization of the human CD8⁺ T cell response following infection with 2009 pandemic influenza H1N1 virus.鉴定人感染 2009 年大流行流感 H1N1 病毒后 CD8⁺ T 细胞的反应。
J Virol. 2011 Nov;85(22):12057-61. doi: 10.1128/JVI.05204-11. Epub 2011 Sep 14.